SCHEMBL27800056

SCHEMBL27800056

COc1ccc(Cn2nc(OC)c3ccccc32)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 4/20 0.80
▸ CNR1 P21554 2/20 0.80
▸ ACHE P22303 1/20 0.57
▸ BCHE P06276 1/20 0.54
▸ PTGER4 P35408 1/20 0.54
▸ P2RX4 Q99571 1/20 0.54
▸ KDM4E B2RXH2 2/20 0.52
▸ CHRM1 P11229 2/20 0.52
▸ GUCY1B2 O75343 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CHRM2 P08172 1/20 0.52
▸ HTR1A P08908 1/20 0.52
▸ ADRA2A P08913 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ DRD1 P21728 1/20 0.52
▸ SLC6A2 P23975 1/20 0.52
▸ SLC6A4 P31645 1/20 0.52
▸ GUCY1A2 P33402 1/20 0.52
▸ ADRA1A P35348 1/20 0.52
▸ OPRM1 P35372 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2760339 0.89 CNR2 (0.70) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL9917500 0.89 CNR2 (1.00) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL516738 0.85 CNR2 (0.67) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL19793130 0.84 CNR2 (0.66) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL30415447 0.84 CNR2 (0.66) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL516208 0.84 CNR2 (0.66) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL16122909 0.84 CNR2 (0.66) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL927918 0.83 CNR1 (0.64) CNR2CNR1ACHEPTGER4P2RX4
SCHEMBL17508619 0.82 CNR2 (0.63) CNR2CNR1ACHEBCHEPTGER4
SCHEMBL12327729 0.81 CNR2 (0.62) CNR2CNR1ACHEBCHEPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101965337-B Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 ACRAF 2013-11-06 — — CN disclosed
CN-101965337-A Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 ACRAF 2011-02-02 — — CN disclosed
CN-101952256-A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 ACRAF 2011-01-19 — — CN disclosed
CN-101945855-A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 ACRAF 2011-01-12 — — CN disclosed
Send feedback